Hemoglobin A1c targets for glycemic control with pharmacologic therapy: In response

Timothy J. Wilt; Michael J. Barry; Devan Kansagara; Amir Qaseem

doi:10.7326/L18-0373

Hemoglobin A_1c targets for glycemic control with pharmacologic therapy: In response

Timothy J. Wilt, Michael J. Barry, Devan Kansagara, Amir Qaseem

Medical Informatics and Clinical Epidemiology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	513
Number of pages	1
Journal	Annals of internal medicine
Volume	169
Issue number	7
DOIs	https://doi.org/10.7326/L18-0373
State	Published - Oct 2 2018

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/L18-0373

Cite this

@article{c88dc540d82a4b3ca01ee09de13c2b21,

title = "Hemoglobin A1c targets for glycemic control with pharmacologic therapy: In response",

author = "Wilt, {Timothy J.} and Barry, {Michael J.} and Devan Kansagara and Amir Qaseem",

year = "2018",

month = oct,

day = "2",

doi = "10.7326/L18-0373",

language = "English (US)",

volume = "169",

pages = "513",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "7",

}

TY - JOUR

T1 - Hemoglobin A1c targets for glycemic control with pharmacologic therapy

T2 - In response

AU - Wilt, Timothy J.

AU - Barry, Michael J.

AU - Kansagara, Devan

AU - Qaseem, Amir

PY - 2018/10/2

Y1 - 2018/10/2

UR - http://www.scopus.com/inward/record.url?scp=85054207179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054207179&partnerID=8YFLogxK

U2 - 10.7326/L18-0373

DO - 10.7326/L18-0373

M3 - Letter

C2 - 30285195

AN - SCOPUS:85054207179

SN - 0003-4819

VL - 169

SP - 513

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 7

ER -

Hemoglobin A1c targets for glycemic control with pharmacologic therapy: In response

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Hemoglobin A_1c targets for glycemic control with pharmacologic therapy: In response